Voyager Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Voyager Therapeutics, Inc. (VYGR) reported Basic Shares Outstanding (Weighted Average) of 60.55 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 60.55M shares, a 3.21% increase year-over-year.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 59.50M shares, a 1.96% increase year-over-year.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 58.94M shares, a 1.66% increase year-over-year.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 58.80M shares, a 1.65% increase year-over-year.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 58.69M shares, a 1.77% increase from fiscal 2024.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 57.67M shares, a 34.05% increase from fiscal 2023.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 43.02M shares, a 12.16% increase from fiscal 2022.
- Voyager Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 38.36M shares, a 1.83% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 60.55M shares 10-Q · filed 2026-08-06 | 60.03M shares 10-Q · filed 2026-08-06 | 59.66M shares derived: average of 3 quarters · filed 2026-08-06 | 59.45M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 59.50M shares 10-Q · filed 2026-05-07 | 59.22M shares derived: average of 2 quarters · filed 2026-05-07 | 59.08M shares derived: average of 3 quarters · filed 2026-05-07 | 58.98M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 58.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 58.87M shares derived: average of 2 quarters · filed 2026-03-09 | 58.80M shares derived: average of 3 quarters · filed 2026-08-06 | 58.69M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 58.80M shares 10-Q · filed 2025-11-10 | 58.73M shares derived: average of 2 quarters · filed 2026-08-06 | 58.61M shares 10-Q · filed 2025-11-10 | 58.45M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 58.67M shares 10-Q · filed 2026-08-06 | 58.51M shares 10-Q · filed 2026-08-06 | 58.33M shares derived: average of 3 quarters · filed 2026-08-06 | 58.21M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 58.35M shares 10-Q · filed 2026-05-07 | 58.16M shares derived: average of 2 quarters · filed 2026-05-07 | 58.06M shares derived: average of 3 quarters · filed 2026-05-07 | 57.97M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 57.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 57.91M shares derived: average of 2 quarters · filed 2026-03-09 | 57.85M shares derived: average of 3 quarters · filed 2026-03-09 | 57.67M shares 10-K · filed 2026-03-09 |
| 2024-09-30 | 57.85M shares 10-Q · filed 2025-11-10 | 57.79M shares derived: average of 2 quarters · filed 2025-11-10 | 57.56M shares 10-Q · filed 2025-11-10 | 55.47M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | 57.72M shares 10-Q · filed 2025-08-06 | 57.42M shares 10-Q · filed 2025-08-06 | 54.68M shares derived: average of 3 quarters · filed 2026-03-09 | 51.98M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | 57.12M shares 10-Q · filed 2025-05-06 | 53.16M shares derived: average of 2 quarters · filed 2026-03-09 | 50.06M shares derived: average of 3 quarters · filed 2026-03-09 | 48.42M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | 49.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 46.53M shares derived: average of 2 quarters · filed 2026-03-09 | 45.53M shares derived: average of 3 quarters · filed 2026-03-09 | 43.02M shares 10-K · filed 2026-03-09 |
| 2023-09-30 | 43.86M shares 10-Q · filed 2024-11-12 | 43.69M shares derived: average of 2 quarters · filed 2024-11-12 | 40.96M shares 10-Q · filed 2024-11-12 | 41.64M shares derived: average of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | 43.52M shares 10-Q · filed 2024-08-06 | 42.10M shares 10-Q · filed 2024-08-06 | 40.90M shares derived: average of 3 quarters · filed 2025-03-11 | 40.30M shares derived: average of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | 40.63M shares 10-Q · filed 2024-05-13 | 39.59M shares derived: average of 2 quarters · filed 2025-03-11 | 39.23M shares derived: average of 3 quarters · filed 2025-03-11 | 39.00M shares derived: average of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | 38.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 38.53M shares derived: average of 2 quarters · filed 2025-03-11 | 38.45M shares derived: average of 3 quarters · filed 2025-03-11 | 38.36M shares 10-K · filed 2025-03-11 |
| 2022-09-30 | 38.51M shares 10-Q · filed 2023-11-06 | 38.40M shares derived: average of 2 quarters · filed 2023-11-06 | 38.29M shares 10-Q · filed 2023-11-06 | 38.17M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 38.30M shares 10-Q · filed 2023-08-03 | 38.18M shares 10-Q · filed 2023-08-03 | 38.05M shares derived: average of 3 quarters · filed 2024-02-28 | 37.98M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 38.05M shares 10-Q · filed 2023-05-09 | 37.93M shares derived: average of 2 quarters · filed 2024-02-28 | 37.88M shares derived: average of 3 quarters · filed 2024-02-28 | 37.80M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 37.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 37.79M shares derived: average of 2 quarters · filed 2024-02-28 | 37.72M shares derived: average of 3 quarters · filed 2024-02-28 | 37.67M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 37.78M shares 10-Q · filed 2022-11-08 | 37.68M shares derived: average of 2 quarters · filed 2022-11-08 | 37.62M shares 10-Q · filed 2022-11-08 | 37.54M shares derived: average of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | 37.58M shares 10-Q · filed 2022-08-04 | 37.54M shares 10-Q · filed 2022-08-04 | 37.46M shares derived: average of 3 quarters · filed 2023-03-07 | 37.40M shares derived: average of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | 37.50M shares 10-Q · filed 2022-05-04 | 37.40M shares derived: average of 2 quarters · filed 2023-03-07 | 37.35M shares derived: average of 3 quarters · filed 2023-03-07 | 37.27M shares derived: average of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | 37.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 37.27M shares derived: average of 2 quarters · filed 2023-03-07 | 37.19M shares derived: average of 3 quarters · filed 2023-03-07 | 37.13M shares 10-K · filed 2023-03-07 |
| 2020-09-30 | 37.24M shares 10-Q · filed 2021-11-02 | 37.14M shares derived: average of 2 quarters · filed 2021-11-02 | 37.08M shares 10-Q · filed 2021-11-02 | |
| 2020-06-30 | 37.03M shares 10-Q · filed 2020-08-10 | 37.00M shares 10-Q · filed 2020-08-10 | ||
| 2019-12-31 | 36.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 36.80M shares derived: average of 2 quarters · filed 2022-03-08 | 36.73M shares derived: average of 3 quarters · filed 2022-03-08 | 35.90M shares 10-K · filed 2022-03-08 |
| 2019-09-30 | 36.74M shares 10-Q · filed 2020-11-09 | 36.68M shares derived: average of 2 quarters · filed 2020-11-09 | 35.58M shares 10-Q · filed 2020-11-09 | |
| 2019-06-30 | 36.61M shares 10-Q · filed 2020-08-10 | 34.99M shares 10-Q · filed 2020-08-10 | ||
| 2018-12-31 | 32.07M shares 10-K · filed 2021-02-25 | |||
| 2018-06-30 | 31.98M shares 10-Q · filed 2019-08-09 | 31.87M shares 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |